EFH, Oncor, Vistra – A Corporate Restructuring for the Decades
In some ways, it was more saga than bankruptcy: A four-year-long, $45 billion corporate restructuring that included the elimination of more than $20 billion in debt, four corporate M&A divestitures valued at $18 billion each, heated battles with state regulators that caused two of those deals to collapse, and the $20 billion spin-off of two subsidiaries. And now its a finalist in the Outstanding Corporate Counsel Awards. Mark Curriden describes the EFH journey through the courts in The Texas Lawbook.



















